19th Annual International Lung Cancer Congress®

SUN	MON	TUES	WED	THURS	FRI	SAT
		1 Medical Crossfire®: Practical Considerations for Integrations of Biosimilars Into Patient Care Pathways for Hematologic Malignancies Expires on Nov 01, 2022 CME 1.5	2	3 Medical Crossfire®: How Should We Leverage Immunotherapeutic and Targeted Strategies Across Lines of Care in Bladder Cancer? Expires on Nov 03, 2022 CME 2.0	4 Exploring Emerging Immunotherapies in Melanoma Expires on Nov 04, 2022 CME 0.5	5
6	7	8	9 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow® November 9, 2022 - November 11, 2022 New York, NY	10	11 Community Practice Connections™: The 5th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) Expires on Nov 11, 2022 CME 2.0	12 Advances In™ Overcoming Barriers to Diagnosis and Treatment of Helicobacter pylori Infections Expires on Nov 12, 2022 CME 1.0 17th Annual New York Lung Cancers Symposium® November 12, 2022 New York, NY
13	14	15 Oncology Briefings™: Update for Nurses on Novel Treatment and Management of ITP Expires on Nov 15, 2022 CME Advances In™ Follicular Lymphoma: Highlighting the Latest Practice Changing-Evidence in Treatment Expires on Nov 15, 2022 CME 1.5 Advances in™ ALK+ NSCLC: Leveraging Evidence and Patient Characteristics to Inform Treatment Expires on Nov 15, 2022 CME 0.75 Understanding Best Care Practices for Hemorrhagic Stroke: A Focus on the Role of DOAC Reversals Expires on Nov 15, 2022 CME 1.0 Expert Illustrations & Commentaries™: Harnessing the Power of KRAS Inhibition to Treat Solid Tumors Expires on Nov 15, 2022 CME 1.0	16 Community Practice Connections™: Alpha-1 Antitrypsin Deficiency—Strategies to Optimize Screening, Diagnosis, and Management Expires on Nov 16, 2022 CME 1.0	17	18	19
20	21	22 4th Annual Advanced Practice Collaborative (APC) Expires on Nov 22, 2022 CME 6.5	23 Community Practice Connections™: 18th Annual Meeting of the International Society of Gastrointestinal Oncology® Expires on Nov 23, 2022 CME 2.0	24	25	26
27	28	29 Community Practice Connections™: How Are We Meeting the Needs of Patients With CLL Across Lines of Care? Expires on Nov 29, 2022 CME 1.50	30 Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED Expires on Nov 30, 2022 CME 1.0 Advances In™: Testing and Treatment of Metastatic CRPC with PARP Inhibitors Expires on Nov 30, 2022 CME 0.5 Advances In™ Hematology: New Therapeutic Options to Treat AL Amyloidosis Expires on Nov 30, 2022 CME 1.5 Community Practice Connections™: How the Experts Approach Testing and Treatment When Utilizing PARP Inhibitors for mCRPC Expires on Nov 30, 2022 CME 2.0 Optimizing Use of T-Cell–Engaging Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia Expires on Nov 30, 2022 CME 1.0 Community Practice Connections™: Navigating the Latest Evidence to Optimize Utilization of Novel Therapies in R/R CML Expires on Nov 30, 2022 CME 1.0 Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors Expires on Nov 30, 2022 CME 1.5 BURST Clinical Consultations: Addressing Long-term Cardiac and Renal Outcomes in Fabry Disease Expires on Nov 30, 2022 CME 0.5 Oncology Best Practice™ Series: Key Questions for the Community on the Detection and Treatment of MRD Expires on Nov 30, 2022 CME 1.0 Clinical Vignette: Managing Multiple Myeloma From Newly Diagnosed to Relapsed/Refractory Settings: An Expert Case-Based Discussion Expires on Nov 30, 2022 CME 1.0 3rd Annual Precision Medicine Symposium: An Illustrated Tumor Board Expires on Nov 30, 2022 CME 1.5 Clinical Vignette Series: How Can We Be More Strategic in Treatment Planning for Patients with ALL? Expires on Nov 30, 2022 CME 1.5 Burst Expert Illustrations & Commentaries™: The Impact of Targeted IL-17 Inhibition on the Treatment for Moderate to Severe Plaque Psoriasis Expires on Nov 30, 2022 CME 0.75 Expert Illustrations and Commentaries: Finding the Best Path Forward in PAH Management - A Focus on Prostacyclin Therapy Expires on Nov 30, 2022 CME .75